STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
通过 TLC/VC-FTMS 表征毒素结合神经节苷脂的结构
基本信息
- 批准号:8365529
- 负责人:
- 金额:$ 0.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2012-08-09
- 项目状态:已结题
- 来源:
- 关键词:AffectBindingBiologicalBiological ProcessBiologyCell LineCellsCeramidesCholesterolComplexCoupledCouplingDetectionElectrospray IonizationEndocytosisEpithelial CellsFatty AcidsFundingGD1a gangliosideGangliosidesGlycosphingolipidsGrantHigh Pressure Liquid ChromatographyHumanHydroxylationIntestinesKidneyLabelLengthLipidsMass Spectrum AnalysisMedicineMembraneMembrane MicrodomainsMethodsMonkeysNational Center for Research ResourcesOligosaccharidesPolysaccharidesPrincipal InvestigatorProteinsPulsarReportingResearchResearch InfrastructureResolutionResourcesRoleSamplingSorting - Cell MovementSourceSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSpeedStructureSurfaceTimeToxinUnited States National Institutes of HealthVariantVero Cellsbasecholeragen receptorcostflotillinganglioside receptorpreventresearch studytrafficking
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Glycosphingolipids and gangliosides participate in diverse biological processes, and their biological roles are dependent on the structures of both the oligosaccharide and the ceramide portions. We have used vibrationally cooled (VC)MALDI-FTMS for the detection of labile species followed by their efficient fragmentation by SORI-CAD and IRMPD. GM1 and GD1a gangliosides serve as trafficking receptors for cholera toxin and the related LTIIb toxin, respectively. We assume that GD1a ganglioside of human intestinal cells is not associated with lipid rafts due to its ceramide structural variation, which prevents endocytosis of the LTIIb-GD1a complex. The toxin receptors' ganglioside structures were evaluated as a moderator of this function, including ceramide chain length, level of saturation and hydroxylation, as well as glycan composition. To analyze these molecules, our previously developed method of direct coupling of TLC plates with VC-MALDI-FTMS was used. This allows direct TLC-MALDI-FTMS without adversely affecting the FT high resolution and mass accuracy by the surface irregularity of the TLC plate. Our earlier reports have described ganglioside purification from polarized intestinal epithelial cell line T-84 and monkey kidney Vero cells and functional studies on the mechanism of toxin biology. The samples were MALDI-desorbed directly off TLC plate surfaces with ~0.2 mm sampling steps. Fragmentation was subsequently performed by SORI-CAD and IRMPD. Both sialylated and highly fucosylated glycosphingolipids were observed. GC/MS analysis of released lipids and glycans were consistent with these observations. In recent experiments, GM1 has been modified with a fluorescent label and its traffic within the cells has been followed. Lencer's group has now determined that only GM1 with unsaturated acyl chains sorts efficiently from PM to the ER. Toxin binding was required, but other membrane components were also required, including cholesterol and the lipid raft protein flotillin. In the BUSM Mass Spectrometry Resource, the difference based on N-acyl fatty acid chains, degree of saturations, etc. of GM1 or fluorescent labeled GM1 is being investigated by high performance liquid chromatography coupled to an electrospray ionization (ESI) QStar Pulsar i time-of-flight (TOF) MS which combines, speed, sensitivity, high mass accuracy and high resolution. MALDI and ESI MS are also being used to verify that the fluorescent label is stable under the cellular conditions.
这个子项目是利用资源的许多研究子项目之一。
由NIH/NCRR资助的中心拨款提供。对子项目的主要支持
子项目的首席调查员可能是由其他来源提供的,
包括美国国立卫生研究院的其他来源。为子项目列出的总成本可能
表示该子项目使用的中心基础设施的估计数量,
不是由NCRR赠款提供给次级项目或次级项目工作人员的直接资金。
鞘糖脂和神经节苷脂参与多种生物学过程,它们的生物学作用依赖于寡糖和神经酰胺部分的结构。我们使用了振动冷却(VC)MALDI-FTMS来检测不稳定物种,然后用Sori-CAD和IRMPD对它们进行有效的碎裂。GM1和GD1a神经节苷脂分别作为霍乱毒素和相关LTIIb毒素的转运受体。我们假设人类肠道细胞的GD1a神经节苷脂与脂筏无关,因为它的神经酰胺结构变化阻止了LTIIb-GD1a复合体的内吞作用。毒素受体的神经节苷脂结构被评估为调节这一功能的因素,包括神经酰胺链长度、饱和程度和羟化程度以及多糖组成。为了分析这些分子,我们使用了我们以前开发的薄层板与VC-MALDI-FTMS直接偶联的方法。这允许直接TLC-MALDI-FTMS,而不会因TLC板的表面不规则性而对FT的高分辨率和质量准确度产生不利影响。我们早期的报道描述了从极化的肠上皮细胞系T-84和猴肾Vero细胞中分离纯化神经节苷脂,并对毒素的生物学机制进行了功能研究。样品直接从TLC板表面以~0.2 mm的采样步长进行MALDI解吸。随后用Sori-CAD和IRMPD进行碎裂。观察到唾液酸化和高度岩藻糖化的鞘糖脂。对释放的脂类和多糖进行的GC/MS分析与这些观察结果一致。在最近的实验中,GM1被修饰了荧光标记,并对其在细胞内的交通进行了跟踪。Lencer的团队现在已经确定,只有带有不饱和酰基链的GM1才能有效地从PM到ER进行排序。毒素结合是必需的,但其他膜成分也是必需的,包括胆固醇和脂筏蛋白Flotillin。在BUSM质谱库中,GM1或荧光标记的GM1基于N-酰基脂肪链、饱和度等的差异正在通过高效液相色谱与电喷雾电离(ESI)QStar Pulsar I飞行时间(TOF)MS相结合进行研究,该MS结合了速度、灵敏度、高质量精度和高分辨率。MALDI和ESI MS也被用于验证荧光标记在细胞条件下是否稳定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAYNE I LENCER其他文献
WAYNE I LENCER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAYNE I LENCER', 18)}}的其他基金
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
IBD 风险基因 INAVA 的作用机制:炎症和肠道屏障完整性的上皮保护受体
- 批准号:
10214604 - 财政年份:2020
- 资助金额:
$ 0.38万 - 项目类别:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
IBD 风险基因 INAVA 的作用机制:炎症和肠道屏障完整性的上皮保护受体
- 批准号:
10626015 - 财政年份:2020
- 资助金额:
$ 0.38万 - 项目类别:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
IBD 风险基因 INAVA 的作用机制:炎症和肠道屏障完整性的上皮保护受体
- 批准号:
10405643 - 财政年份:2020
- 资助金额:
$ 0.38万 - 项目类别:
Intestinal Disease-enterocyte toxin interaction
肠道疾病-肠细胞毒素相互作用
- 批准号:
9263933 - 财政年份:2016
- 资助金额:
$ 0.38万 - 项目类别:
Intestinal Disease-enterocyte toxin interaction
肠道疾病-肠细胞毒素相互作用
- 批准号:
9167689 - 财政年份:2016
- 资助金额:
$ 0.38万 - 项目类别:
Intestinal Disease-enterocyte toxin interaction
肠道疾病-肠细胞毒素相互作用
- 批准号:
9899224 - 财政年份:2016
- 资助金额:
$ 0.38万 - 项目类别:
Unsaturated glycoceramide as novel platform for mucosal vaccine and drug delivery
不饱和甘油酰胺作为粘膜疫苗和药物输送的新平台
- 批准号:
8145606 - 财政年份:2010
- 资助金额:
$ 0.38万 - 项目类别:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
通过 TLC/VC-FTMS 表征毒素结合神经节苷脂的结构
- 批准号:
8170895 - 财政年份:2010
- 资助金额:
$ 0.38万 - 项目类别:
Unsaturated glycoceramide as novel platform for mucosal vaccine and drug delivery
不饱和甘油酰胺作为粘膜疫苗和药物输送的新平台
- 批准号:
8030610 - 财政年份:2010
- 资助金额:
$ 0.38万 - 项目类别:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
上皮细胞对 IgG 和 IgG 视蛋白化抗原的 FcRn 依赖性分选
- 批准号:
8538945 - 财政年份:2009
- 资助金额:
$ 0.38万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 0.38万 - 项目类别:
Standard Grant
Modelling drug binding to biological ion channels
模拟药物与生物离子通道的结合
- 批准号:
2747257 - 财政年份:2022
- 资助金额:
$ 0.38万 - 项目类别:
Studentship
Elucidation of biological functions of the NCBP3 RNA-binding protein using a novel mutant mouse strain
使用新型突变小鼠品系阐明 NCBP3 RNA 结合蛋白的生物学功能
- 批准号:
22K06065 - 财政年份:2022
- 资助金额:
$ 0.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identifying binding partners, biological substrates and antisense oligonucleotides regulating expression of short and long ACE2.
识别调节短和长 ACE2 表达的结合伴侣、生物底物和反义寡核苷酸。
- 批准号:
BB/V019848/1 - 财政年份:2021
- 资助金额:
$ 0.38万 - 项目类别:
Research Grant
Structure and function of pufferfish toxin, tetrodotoxin, binding proteins as biological defense agent
河豚毒素、河豚毒素、结合蛋白作为生物防御剂的结构和功能
- 批准号:
19K06241 - 财政年份:2019
- 资助金额:
$ 0.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The molecular and biological roles of growth inhibiting chromatin binding proteins
生长抑制染色质结合蛋白的分子和生物学作用
- 批准号:
nhmrc : GNT1143612 - 财政年份:2018
- 资助金额:
$ 0.38万 - 项目类别:
Project Grants
Investigating a biological specificity conundrum: the role of dynamics in transcription factor binding
研究生物特异性难题:动力学在转录因子结合中的作用
- 批准号:
406750 - 财政年份:2018
- 资助金额:
$ 0.38万 - 项目类别:
Studentship Programs
Electrical Detection of Small Molecule Binding to Biological Receptors using Organic Thin Film Transistors : A new approach for label free assays
使用有机薄膜晶体管对小分子与生物受体结合的电检测:一种无标记测定的新方法
- 批准号:
133593 - 财政年份:2018
- 资助金额:
$ 0.38万 - 项目类别:
Feasibility Studies
Biological effect and preventive method for human serum albumin binding to transboundary air borne PM2.5.
人血清白蛋白与跨境空气PM2.5结合的生物学效应及预防方法。
- 批准号:
18H03039 - 财政年份:2018
- 资助金额:
$ 0.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The molecular and biological roles of growth inhibiting chromatin binding proteins
生长抑制染色质结合蛋白的分子和生物学作用
- 批准号:
nhmrc : 1143612 - 财政年份:2018
- 资助金额:
$ 0.38万 - 项目类别:
Project Grants